BridgeBio Pharma Inventory Turnover Ratio 2018-2023 | BBIO
BridgeBio Pharma inventory turnover ratio from 2018 to 2023. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period.
| BridgeBio Pharma Inventory Turnover Ratio Historical Data | |||
|---|---|---|---|
| Date | |||
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $4.656B | $0.009B |
| BridgeBio Pharma Inc. discovers, develops and innovates drugs for genetic diseases. The Company's product platform consists of Mendelian, Oncology and Gene therapy. Its product pipeline includes BBP-265, BBP-831, BBP-631 and BBP-454 which are in clinical stage. BridgeBio Pharma Inc. is based in CA, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $15.482B | 5.59 |
| Dr Reddy's Laboratories (RDY) | India | $12.441B | 19.67 |
| Aspen Pharmacare (APNHY) | South Africa | $5.038B | 0.00 |
| Bausch Health Cos (BHC) | Canada | $3.183B | 2.48 |
| Amphastar Pharmaceuticals (AMPH) | United States | $2.009B | 13.75 |
| Supernus Pharmaceuticals (SUPN) | United States | $1.646B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $0.447B | 0.00 |
| Generation Bio (GBIO) | United States | $0.193B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.069B | 0.00 |
| Personalis (PSNL) | United States | $0.064B | 0.00 |
| Acasti Pharma (ACST) | Canada | $0.027B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.025B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.004B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |